Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Kitajima

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
Scientific Reports|April 20, 2021
Usefulness of semi-automatic harmonization strategy of standardized uptake values for multicenter PET studiesHiromitsu Daisaki, Kazuhiro Kitajima, Masatoyo Nakajo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 18, 2016
Multiparametric magnetic resonance imaging: Current role in prostate cancer managementYoshiko Ueno, Tsutomu Tamada, Vipul Bist, et al.
European Journal of Radiology|June 18, 2013
Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasisYuko Suenaga, Kazuhiro Kitajima, Hajime Aoki, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|March 23, 2018
[Simulation at Incomplete Acquisition on Stress-rest Cerebral Blood Flow Quantitative Values One Day Method]Tatsuya Tsuchitani, Yoshihiro Maeda, Masahiko Oda, et al.
Nagoya Journal of Medical Science|December 28, 2018
Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinomaHiroshi Doi, Masayuki Fujiwara, Kazuhiro Kitajima, et al.
European Radiology|March 23, 2019
Early evaluation of tumor response to <sup>90</sup>Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?Kazuhiro Kitajima, Masaya Okada, Toru Kashiwagi, et al.
Radiology|May 6, 2015
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass SpectroscopyTomonori Kanda, Toshio Fukusato, Megumi Matsuda, et al.
Expert Review of Anticancer Therapy|June 9, 2017
First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesotheliomaEriko Fujimoto, Takashi Kijima, Kozo Kuribayashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2009
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
European Journal of Radiology|July 5, 2011
Thyroid size change by CT monitoring after sorafenib or sunitinib treatment in patients with renal cell carcinoma: comparison with thyroid functionKazuhiro Kitajima, Satoru Takahashi, Tetsuo Maeda, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
Scientific Reports|April 20, 2021
Usefulness of semi-automatic harmonization strategy of standardized uptake values for multicenter PET studiesHiromitsu Daisaki, Kazuhiro Kitajima, Masatoyo Nakajo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 18, 2016
Multiparametric magnetic resonance imaging: Current role in prostate cancer managementYoshiko Ueno, Tsutomu Tamada, Vipul Bist, et al.
European Journal of Radiology|June 18, 2013
Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasisYuko Suenaga, Kazuhiro Kitajima, Hajime Aoki, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|March 23, 2018
[Simulation at Incomplete Acquisition on Stress-rest Cerebral Blood Flow Quantitative Values One Day Method]Tatsuya Tsuchitani, Yoshihiro Maeda, Masahiko Oda, et al.
Nagoya Journal of Medical Science|December 28, 2018
Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinomaHiroshi Doi, Masayuki Fujiwara, Kazuhiro Kitajima, et al.
European Radiology|March 23, 2019
Early evaluation of tumor response to <sup>90</sup>Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?Kazuhiro Kitajima, Masaya Okada, Toru Kashiwagi, et al.
Radiology|May 6, 2015
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass SpectroscopyTomonori Kanda, Toshio Fukusato, Megumi Matsuda, et al.
Expert Review of Anticancer Therapy|June 9, 2017
First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesotheliomaEriko Fujimoto, Takashi Kijima, Kozo Kuribayashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2009
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CTKazuhiro Kitajima, Koji Murakami, Erena Yamasaki, et al.
European Journal of Radiology|July 5, 2011
Thyroid size change by CT monitoring after sorafenib or sunitinib treatment in patients with renal cell carcinoma: comparison with thyroid functionKazuhiro Kitajima, Satoru Takahashi, Tetsuo Maeda, et al.
Pageof 25